News
Researchers at Rutgers University-New Brunswick (N.J.) are questioning the FDA’s 2020 decision to place a safety warning on a common antiseizure medication. Lamictal (lamotrigine), a GSK medicine ...
Rutgers Health researchers found that lamotrigine, a widely prescribed antiseizure medication, to be safe in older adults ...
Rutgers Health researchers found that lamotrigine, a widely prescribed antiseizure medication, to be safe in older adults ...
JUNE 10, 2025 — UTSA researchers in the Max and Minnie Tomerlin Voelcker CIDD Preclinical Pharmacology Core for Accelerated ...
For the study, investigators will use EEG to monitor brain activity in dogs with epilepsy and compare the frequency and type ...
First-time seizures in adults could be caused by a stroke, metabolic imbalances, or brain injury. Learn about why seizures ...
Now, a new study from Queen Mary University of London has found a possible link between some of these epilepsy drugs and an ...
A large-scale study conducted across 19 universities and hospitals in Thailand, along with the Ministry of Public Health, ...
Study: Cannabis-Based Treatments Associated With Seizure Freedom in Drug-Resistant Epilepsy Patients
A new case series published in the journal Frontiers in Neuroscience details how cannabis-based products led to seizure ...
SGLT-2 inhibitor use vs DPP-4 inhibitor use was associated with lower incidence of epilepsy among patients with type 2 diabetes.
Midtown-based drug discovery startup GRIN Therapeutics has reached a deal with Angelini Pharma to commercialize its signature ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results